Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014

  Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014

Business Wire

NEW YORK -- November 14, 2013

Pfizer Inc. (NYSE: PFE) today announced that Wyeth LLC, its wholly owned
subsidiary, has notified The Bank of New York Mellon, as trustee under the
applicable indenture, of its election to fully redeem all of its outstanding
5.500% Notes due February 1, 2014 (CUSIP No. 983024AE0) (the “Notes”). The
aggregate principal amount of Notes currently outstanding is $1.75 billion.
The redemption date for the Notes will be December 16, 2013 (the “Redemption

The redemption price (“Redemption Price”) for the Notes will be a price equal
to the greater of (i) 100% of the principal amount of the Notes, or (ii) the
sum, as determined by the Quotation Agent (as defined in the Global Note, the
form of which was filed with the Securities and Exchange Commission as part of
Exhibit 4.6 to Wyeth’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2003 (File No. 001-01225) (the “Global Note”)), of the present
value of the principal amount of the Notes and the remaining scheduled
payments of interest on the Notes from the Redemption Date to the maturity
date of the Notes, exclusive of interest accrued to the Redemption Date,
discounted from their respective scheduled payment dates to the Redemption
Date on a semiannual basis (assuming a 360-day year of twelve 30-day months)
at the Treasury Rate (as defined in the Global Note) plus 25 basis points,
plus accrued and unpaid interest on the principal amount being redeemed to
(but excluding) the Redemption Date.

On and after the Redemption Date, the Redemption Price will become due and
payable in respect of the Notes, and interest on the Notes will cease to
accrue on and after such date.

Notice of the redemption of the Notes (the “Notice of Redemption”) is expected
to be mailed on November 14, 2013. The redemption will be effected in
accordance with the applicable terms of the indenture under which the Notes
were issued.

The paying agent for the redemption is The Bank of New York Mellon. The
relevant contact information for The Bank of New York Mellon will be set forth
in the Notice of Redemption.

This announcement is neither an offer to sell nor a solicitation of an offer
to buy any of the Notes and shall not constitute an offer, solicitation or
sale in any jurisdiction in which such offer, solicitation or sale is

Pfizer Inc: Working together for a healthier world®

At Pfizer, we apply science and our global resources to bring therapies to
people that extend and significantly improve their lives. We strive to set the
standard for quality, safety and value in the discovery, development and
manufacturing of health care products. Our global portfolio includes medicines
and vaccines as well as many of the world's best-known consumer health care
products. Every day, Pfizer colleagues work across developed and emerging
markets to advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our responsibility as
one of the world's premier innovative biopharmaceutical companies, we
collaborate with health care providers, governments and local communities to
support and expand access to reliable, affordable health care around the
world. For more than 150 years, Pfizer has worked to make a difference for all
who rely on us. To learn more, please visit us at


Pfizer Inc.
Media: Joan Campion, 212-733-2798
Investors: Suzanne Harnett, 212-733-8009
Press spacebar to pause and continue. Press esc to stop.